Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Management of Chronic Tinea Cruris

Diagnosis Confirmation

  • Accurate diagnosis should be confirmed through microscopy using potassium hydroxide preparation or culture to identify the causative organism 1
  • Specimens should be collected using scalpel scraping or swab as appropriate to the lesion 2
  • Laboratory confirmation is advisable to isolate the causal organism and direct the choice of therapy 3

Treatment Algorithm

  • For chronic or resistant cases, oral antifungal therapy is indicated when infection is resistant to topical treatment, with options including terbinafine and itraconazole 1

Treatment Selection Considerations

  • Treatment duration should be based on clinical response and causative organism 1

Prevention of Recurrence

  • Implement preventive measures to avoid recurrence, including avoiding skin-to-skin contact with infected individuals, not sharing personal items, covering lesions, and keeping affected areas clean and dry 1
  • Screen and treat family members if infection is caused by anthropophilic species 1

Monitoring and Follow-up

  • The definitive endpoint for treatment should be mycological cure, not just clinical response 1
  • Follow-up should include both clinical and mycological assessment 1
  • Treatment failure may require extending treatment duration or switching to an alternative antifungal 1
  • Repeat mycology sampling is recommended until mycological clearance is documented 1

Common Pitfalls

  • Not considering secondary bacterial infection in inflammatory cases 3
  • Stopping treatment too early based only on clinical improvement rather than mycological cure 1

REFERENCES